September 18, 2017 09:20 AM EDTUpdated 09:39 AM
News Briefing

Avanir vet Kei­th Katkin takes charge at Urovant; Te­va un­loads as­sets while up­load­ing new CEO

Shehla Shakoor

Managing Director

⇨ Roivant Sci­ences has added an­oth­er sea­soned biotech ex­ec to its sta­ble of CEOs. The um­brel­la group an­nounced this morn­ing that Kei­th Katkin, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Dai­ichi Sankyo finds suc­ces­sor to late R&D ex­ec; Ver­sant, No­var­tis' kid­ney biotech poach­es Sana CBO

A service from the Financial Times